Literature DB >> 17402355

[Disease management for heart failure patients: role of wireless technologies for telemedicine. The ICAROS project].

Alessandra Villani1, Gabriella Malfatto, Francesco Della Rosa, Giovanna Branzi, Simona Boarin, Claudio Borghi, Eugenio Cosentino, Massimo Gualerzi, Paolo Coruzzi, Enrico Molinari, Angelo Compare, Maurizio Cassi, Stefano Collatina, Gianfranco Parati.   

Abstract

Healthcare costs for heart failure are increasing. The need for a better care, however, has to be matched with a policy of cost containment. A way to improve the cost-effectiveness of heart failure care is the disease management approach, in which therapy, education and follow-up are tailored for each patient by a multidisciplinary team. Such a complex intervention can be facilitated by the use of telemedicine, which allows the remote control of considerable amounts of clinical data. In Italy, a few studies with telemedicine have been reported. A recent development in this field is represented by the ICAROS project (Integrated Care vs Conventional Intervention in Cardiac Failure Patients: Randomized Open Label Study), whose aim is to improve the clinical and psychological care of heart failure patients employing advanced wireless telecommunication technology. So far, we randomized 60 patients: 30 in usual ambulatory care, 30 in an intensive treatment group. The latter patients were instructed to use a portable computer to get in touch daily with the heart failure clinic and receive feedback instruction for the management of drug therapy and daily problems. At the first year of follow-up, the treatment group showed good compliance to drug prescriptions, and could easily handle the portable computer. The preliminary results of this ongoing study support the feasibility and appropriateness of new technologies for the management of heart failure, even in elderly patients in whom a limited expertise with these appliances could have been anticipated.

Entities:  

Mesh:

Year:  2007        PMID: 17402355

Source DB:  PubMed          Journal:  G Ital Cardiol (Rome)        ISSN: 1827-6806


  6 in total

1.  In Sickness and in Health: a Literature Review about Function of Social Support within Anxiety and Heart Disease Association.

Authors:  Cristina Zarbo; Angelo Compare; Elena Baldassari; Alberto Bonardi; Claudia Romagnoni
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-12-27

Review 2.  Comparative effectiveness of different forms of telemedicine for individuals with heart failure (HF): a systematic review and network meta-analysis.

Authors:  Ahmed Kotb; Chris Cameron; Shuching Hsieh; George Wells
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

3.  Social support, depression, and heart disease: a ten year literature review.

Authors:  Angelo Compare; Cristina Zarbo; Gian Mauro Manzoni; Gianluca Castelnuovo; Elena Baldassari; Alberto Bonardi; Edward Callus; Claudia Romagnoni
Journal:  Front Psychol       Date:  2013-07-01

Review 4.  Interactive telemedicine: effects on professional practice and health care outcomes.

Authors:  Gerd Flodgren; Antoine Rachas; Andrew J Farmer; Marco Inzitari; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2015-09-07

5.  Combining personality traits with traditional risk factors for coronary stenosis: an artificial neural networks solution in patients with computed tomography detected coronary artery disease.

Authors:  Angelo Compare; Enzo Grossi; Massimo Buscema; Cristina Zarbo; Xia Mao; Francesco Faletra; Elena Pasotti; Tiziano Moccetti; Paula M C Mommersteeg; Angelo Auricchio
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-10-03

6.  PAHA study: psychological active and healthy aging: psychological wellbeing, proactive attitude and happiness effects of whole-body vibration versus Multicomponent Training in aged women: study protocol for a randomized controlled trial.

Authors:  Angelo Compare; Cristina Zarbo; Elena Marín; Alessia Meloni; Jacobo A Rubio-Arias; Rosendo Berengüí; Enzo Grossi; Edo Shonin; Gianmaria Martini; Pedro E Alcaraz
Journal:  Trials       Date:  2014-05-20       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.